Medpace Q3 revenue $295.6M (+28.3%), EPS $1.29; net new awards $408M

Medpace Holdings, Inc.

2021-Q3 EPS reported $3.49 revenue$833,825,000

Revenue $295.6M, up 28.3% YoY; net income $48.6M ($1.29 diluted EPS) vs $41.5M ($1.09) prior year.
Net new business awards $408M, up 29.4%, book-to-bill 1.38x; backlog $1.8B (+29%).
EBITDA $60.1M (20.3% margin) vs $51.9M (22.5%) prior year; net income margin 16.4% vs 18%.
Constant currency organic revenue growth 28.1%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.